ZA200600642B - IL-17 A/F heterologous polypeptides and therapeutic uses thereof - Google Patents

IL-17 A/F heterologous polypeptides and therapeutic uses thereof

Info

Publication number
ZA200600642B
ZA200600642B ZA200600642A ZA200600642A ZA200600642B ZA 200600642 B ZA200600642 B ZA 200600642B ZA 200600642 A ZA200600642 A ZA 200600642A ZA 200600642 A ZA200600642 A ZA 200600642A ZA 200600642 B ZA200600642 B ZA 200600642B
Authority
ZA
South Africa
Prior art keywords
therapeutic uses
heterologous polypeptides
heterologous
polypeptides
therapeutic
Prior art date
Application number
ZA200600642A
Inventor
Arnott David
Gurney Austin
Hass Philip
Lee James
Wu Yan
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA200600642B publication Critical patent/ZA200600642B/en

Links

ZA200600642A 2003-07-08 2004-06-02 IL-17 A/F heterologous polypeptides and therapeutic uses thereof ZA200600642B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48559903P 2003-07-08 2003-07-08

Publications (1)

Publication Number Publication Date
ZA200600642B true ZA200600642B (en) 2007-06-27

Family

ID=40566436

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200600642A ZA200600642B (en) 2003-07-08 2004-06-02 IL-17 A/F heterologous polypeptides and therapeutic uses thereof

Country Status (1)

Country Link
ZA (1) ZA200600642B (en)

Similar Documents

Publication Publication Date Title
HUS1600046I1 (en) Il-17 a/f heterologous polypeptides and therapeutic uses thereof
HK1205748A1 (en) Therapeutic epitopes and uses thereof
EP1682136A4 (en) Therapeutic compounds and uses thereof
GB2403015B (en) Pressure gage and switch
IL207422A0 (en) Improved recombinant human interferon-beta-ib polypeptides
SG122903A1 (en) Therapeutic peptides and method
GB0210517D0 (en) Material
AP2127A (en) Multi-carbide material manufacture and use
EP1645563A4 (en) Protein-refolding material
EP1596813A4 (en) Lung-expressed polypeptides
GB0309064D0 (en) Modified peptides and their uses
HK1209050A1 (en) Survivin-derived peptides and use thereof
ZA200600642B (en) IL-17 A/F heterologous polypeptides and therapeutic uses thereof
EP1692125A4 (en) Irciniastatins a and b
GB0223272D0 (en) A protein involved in therapy
HK1092840A1 (en) Use of a polypeptides
GB0227823D0 (en) Simulated stone material
EP1725584A4 (en) Novel phytochrome-interacting protein and a use thereof
GB0224014D0 (en) A protein involved in therapy
EP1699809A4 (en) Amniotic-derived peptide and uses thereof
GB0224013D0 (en) A protein involved in therapy
AU2003953561A0 (en) Peptides and therapeutic uses thereof
GB0216200D0 (en) Polypeptides and uses thereof
GB0312990D0 (en) Peptides and uses thereof
GB0323193D0 (en) Peptides and uses thereof